首页> 外文期刊>ACS medicinal chemistry letters >Treatment of Amyotrophic Lateral Sclerosis: Lessons Learned from Many Failures
【24h】

Treatment of Amyotrophic Lateral Sclerosis: Lessons Learned from Many Failures

机译:肌萎缩性侧索硬化症的治疗:许多失败的教训

获取原文
获取原文并翻译 | 示例
           

摘要

Amyotrophic lateral sclerosis (ALS) is one of the most complex neurodegenerative diseases, involving both cortical and spinal components of motor neuron circuitry and non-neuronal cells that support the motor neurons. There is no effective therapeutic for ALS, and compounds that have extended the lifespan of ALS mouse models have failed in clinical trials. This viewpoint discusses current information regarding the changing views about ALS and what the failures in clinical trials can teach us in the search for an effective treatment. Previous challenges and roadblocks in drug discovery for ALS are noted, and solutions to current limitations are discussed. Learning from the past and moving forward with a new mindset can translate into successful and effective treatment strategies in ALS and other related diseases.
机译:肌萎缩性侧索硬化症(ALS)是最复杂的神经退行性疾病之一,涉及运动神经元回路的皮质和脊髓成分以及支持运动神经元的非神经元细胞。没有有效的ALS治疗药物,延长ALS小鼠模型寿命的化合物在临床试验中失败。该观点讨论了有关ALS不断变化的观点的最新信息,以及临床试验中的失败可以教会我们寻找有效治疗方法的信息。指出了ALS药物发现中的先前挑战和障碍,并讨论了当前限制的解决方案。从过去学习并以新的思维方式前进可以转化为ALS和其他相关疾病的成功有效的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号